Horn Howard
- SEC CIK
- 0001786335
In the past year, 10 open-market sale filings worth $1.33M and no purchases.
Current role at each company
- RARE Ultragenyx Pharmaceutical Inc.Chief Financial Officeras of Aug 4, 2026
- VIR Vir Biotechnology, Inc.CFOas of Feb 24, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.33M
- 10 filings
- Net
- −$1.33M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Horn Howard as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
RARE Ultragenyx Pharmaceutical Inc.
Chief Financial Officer12 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 4, 2026 (view filing)3:13 PM ET | Aug 3 | 1 day | Horn HowardChief Financial Officer | SSale | −4.70K | $24.92 | −$117.0K | −4.6%96.3K after | 10b5-1 |
| Jul 6, 2026 (view filing)3:37 PM ET | Jul 1 | 5 days | Horn HowardChief Financial Officer | SSale | −4.70K | $33.13 | −$155.6K | −4.4%101.0K after | 10b5-1 |
| Jun 1, 2026 (view filing) | Jun 1 | Same day | Horn HowardChief Financial Officer | SSale | −4.65K | $23.77 | −$110.6K | −4.2%105.7K after | 10b5-1 |
| May 4, 2026 (view filing) | May 1 | 3 days | Horn HowardChief Financial Officer | SSale | −4.68K | $24.90 | −$116.6K | −4.1%110.3K after | 10b5-1 |
| Apr 2, 2026 (view filing) | Apr 1 | 1 day | Horn HowardChief Financial Officer | SSale | −4.68K | $20.97 | −$98.2K | −5.5%80.4K after | 10b5-1 |
| Mar 3, 2026 (view filing) | Mar 2-3 | 1 day | Horn HowardChief Financial Officer | SSale | −10.0K | $22.65 | −$227.5K | −10.6%85.0K after | 3 lots10b5-1 |
| Feb 3, 2026 (view filing) | Feb 2 | 1 day | Horn HowardChief Financial Officer | SSale | −3.06K | $23.56 | −$72.1K | −3.3%88.9K after | 10b5-1 |
| Jan 5, 2026 (view filing) | Jan 2 | 3 days | Horn HowardChief Financial Officer | SSale | −3.15K | $22.84 | −$71.9K | −3.3%92.0K after | 10b5-1 |
| Dec 11, 2025 (view filing) | Dec 10 | 1 day | Horn HowardChief Financial Officer | SSale | −3.08K | $36.38 | −$112.1K | −3.1%95.1K after | 10b5-1 |
| Oct 14, 2025 (view filing) | Oct 13 | 1 day | Horn HowardChief Financial Officer | SSale | −7.94K | $31.51 | −$250.3K | −7.5%98.2K after |
VIR Vir Biotechnology, Inc.
CFO3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 24, 2023 (view filing) | Feb 23 | 1 day | Horn HowardCFO | SSale | −2.25K | $25.97 | −$58.4K | −1.0%230.7K after | |
| Feb 21, 2023 (view filing) | Feb 17 | 4 days | Horn HowardCFO | SSale | −2.42K | $25.29 | −$61.3K | −1.0%233.0K after | |
| Feb 22, 2022 (view filing) | Feb 17 | 5 days | Horn HowardCFO | SSale | −2.39K | $31.93 | −$76.4K | −1.2%200.4K after |